12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Advanced Fibrosis is Associated with Incident Cardiovascular Disease in Patients with Non-Alcoholic Fatty Liver Disease

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Background:

          Nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of cardiovascular disease. It is not well understood, however, which individuals with NAFLD are at highest risk for cardiovascular disease.

          Aims:

          Our aim was to determine the factors associated with incident cardiovascular events in a prospective cohort of individuals with biopsy-proven NAFLD without pre-existing cardiovascular disease.

          Methods:

          From 2011–2018, adults with biopsy-proven NAFLD without cardiovascular disease were enrolled in a tissue repository and were followed prospectively to the first recorded date of incident cardiovascular disease, death, or the end of follow-up (11/1/2018). Competing risks analysis was performed to identify predictors of incident cardiovascular disease.

          Results:

          After a median follow-up time of 5.2 years, 26/285 (9.1%) individuals experienced an incident cardiovascular event. Advanced fibrosis (stage 3–4) on biopsy was a significant predictor of incident cardiovascular disease, and this persisted on multivariable analysis after considering relevant covariates, including cardiovascular risk scores, which were not independent predictors. Of the non-invasive indicators of fibrosis, the NAFLD fibrosis score was the only independent predictor of cardiovascular disease. Other histologic features, including steatohepatitis, were not associated with incident cardiovascular disease.

          Conclusions:

          In adults with biopsy-proven NAFLD, advanced fibrosis on biopsy and higher NAFLD fibrosis score were significant and independent predictors of incident cardiovascular disease, even after considering traditional risk factors and cardiovascular risk scores. These findings should be considered when evaluating NAFLD patients for primary prevention of cardiovascular disease, and further evaluation into the link between advanced fibrosis and cardiovascular disease is needed.

          Related collections

          Author and article information

          Journal
          8707234
          1160
          Aliment Pharmacol Ther
          Aliment. Pharmacol. Ther.
          Alimentary pharmacology & therapeutics
          0269-2813
          1365-2036
          31 January 2020
          11 February 2020
          April 2020
          01 April 2021
          : 51
          : 7
          : 728-736
          Affiliations
          [1 ]Department of Medicine, Massachusetts General Hospital, Boston, MA
          [2 ]Liver Center, Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA
          [3 ]Department of Pathology, Massachusetts General Hospital, Boston, MA
          Author notes

          Authorship Statement:

          Guarantor of article: Kathleen E. Corey

          Authorship contributions: JBH: study concept and design, acquisition of data, analysis and interpretation of data, drafting of the manuscript, statistical analysis; TGS: study concept and design, acquisition of data, analysis and interpretation of data, critical revision of the manuscript for important intellectual content; AK: analysis and interpretation of data, critical revision of the manuscript for important intellectual content; SO: acquisition of data, administrative, technical, or material support; RM: acquisition of data, analysis and interpretation of data; KEC: study concept and design, acquisition of data, analysis and interpretation of data, critical revision of the manuscript for important intellectual content; study supervision.

          Correspondence: Kathleen Corey, MD, MPH, MMSc, Gastrointestinal Unit, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114. kcorey@ 123456partners.org . Tel: 617-724-0274. Fax: 617-724-5997.
          Author information
          http://orcid.org/0000-0001-5496-0590
          Article
          PMC7069774 PMC7069774 7069774 nihpa1552782
          10.1111/apt.15660
          7069774
          32043602
          6ab197e5-78dc-4e2b-9ade-fcf1ddd923ec
          History
          Categories
          Article

          atherosclerosis,hepatic fibrosis,cardiovascular risk,non-alcoholic steatohepatitis

          Comments

          Comment on this article